Obagi Medical Products (OMPI) 12.62 -0.12

Obagi Medical Products, Inc.
(OMPI) 12.62 -0.12

Last Trade:	12.59	Day Range:	12.37 - 12.67
Trade Time:	08:05PM	52wk Range:	8.79 - 13.75
Prev. Close:	12.71	Market Cap:	235.84M
Open:	12.58	Div Yield:	0
Volume:	98866	PE:
EPS:	0.84

The Latest On OMPI

UPDATE: Cantor Fitzgerald Raises PT to $14 on Obagi Medical Products 3/9/12 11:56am

Voce Capital Addresses Response by Obagi Board of Directors to Its Letter 2/17/12 9:30am

Cantor Fitzgerald Reiterates Buy, $12 PT on Obagi Medical Products 2/13/12 10:59am

Voce Capital Sends Letter to Obagi Medical Products Board of Directors; Criticizes Recent Adoption Of Poison Pill And Demands Immediate Action To Rectify Governance 2/10/12 1:23pm

Obagi Medical Products Announces Publication of Study in the July Edition of the Aesthetic Surgery Journal 8/24/11 9:01am

Obagi Medical Products Introduces New Clinical Data Showing Combination of Hydroquinone Skin Care System and Tretinoin May Reduce Melasma Severity 6/21/11 4:15pm

Duncan Williams Maintains Obagi Medical Products Hold 6/9/11 1:15pm

Should Microsoft Corporation (MSFT) buy Skype? 5/10/11 8:41am

Benzinga's Top Downgrades (ASEI, TE, OMPI, GSIC) 5/9/11 8:28am

Duncan-Williams Downgrades Rating, Removes PT On OMPI 5/9/11 7:51am

Obagi Medical Stops Shipping Due to Texas Attorney General Allegations -Bloomberg (OMPI) 5/9/11 7:39am

Updates- LinkedIn IPO, Oil, Yuan, HTZ, DTG, AES, TSN, BID, ATVI, SRE, PETS, RST, SYY, CLR… 5/9/11 7:26am

UPDATE: Cantor Fitzgerald Raises PT to $14 on Obagi Medical Products 3/9/12

Voce Capital Addresses Response by Obagi Board of Directors to Its Letter 2/17/12

Cantor Fitzgerald Reiterates Buy, $12 PT on Obagi Medical Products 2/13/12

Voce Capital Sends Letter to Obagi Medical Products Board of Directors; Criticizes Recent Adoption Of Poison Pill And Demands Immediate Action To Rectify Governance 2/10/12

Obagi Medical Products Announces Publication of Study in the July Edition of the Aesthetic Surgery Journal 8/24/11

Obagi Medical Products Introduces New Clinical Data Showing Combination of Hydroquinone Skin Care System and Tretinoin May Reduce Melasma Severity 6/21/11

Duncan Williams Maintains Obagi Medical Products Hold 6/9/11

Should Microsoft Corporation (MSFT) buy Skype? 5/10/11

Benzinga's Top Downgrades (ASEI, TE, OMPI, GSIC) 5/9/11

Duncan-Williams Downgrades Rating, Removes PT On OMPI 5/9/11

Obagi Medical Stops Shipping Due to Texas Attorney General Allegations -Bloomberg (OMPI) 5/9/11

Updates- LinkedIn IPO, Oil, Yuan, HTZ, DTG, AES, TSN, BID, ATVI, SRE, PETS, RST, SYY, CLR… 5/9/11

Top 5 Small-Cap Stocks In The Biotechnology Industry With The Highest Return On Equity (OMPI, MRX, AOB, EBS, SSRX) 6/3/10

UPDATE: Cantor Fitzgerald Raises PT to $14 on Obagi Medical Products 3/9/12

Cantor Fitzgerald Reiterates Buy, $12 PT on Obagi Medical Products 2/13/12

Duncan Williams Maintains Obagi Medical Products Hold 6/9/11

Benzinga's Top Downgrades (ASEI, TE, OMPI, GSIC) 5/9/11

Duncan-Williams Downgrades Rating, Removes PT On OMPI 5/9/11

Benzinga's Top Downgrades (PCLN, OMPI, WESTD, PSA) 5/6/11

Duncan Williams Raises Obagi Medical Products Rating To Buy, Initiates PT At $14 (OMPI) 3/11/11

Obagi Stays On The Sidelines 11/9/10

Piper Jaffray Reiterates Neutral Rating On Obagi Medical Despite EPS Miss (OMPI) 8/9/10

Obagi Medical Products Research Update (OMPI) 2/3/10

Trade OMPI
NOW!

Partner Headlines

Obagi Puts Its Problems Behind It (OMPI, MRX, VRX, AGN) 5/25/12

Obagi Medical Products Inc. Reports Operating Results (10-Q) 5/4/12

Obagi Medical Products Inc. Reports Operating Results (10-K) 3/8/12

Weekly CFO Sells: LNKD, ENTG, OMPI, Z, THR, SPSC 11/27/11

Obagi Medical Products Inc. Reports Operating Results (10-Q) 11/9/11

Obagi Medical Products Inc. Reports Operating Results (10-Q)

Press Releases

Voce Urges Fellow Obagi Shareholders to Vote Against Poison Pill and Withhold Support for All Directors at June 6th Annual Meeting 5/29/12 Business Wire

THE Aesthetic Academy Rolls Out the Red Carpet for Beverly Hills Celebrity Physicians at Exclusive Media Training Program June 2nd in Beverly Hills 5/22/12 Business Wire

Obagi Medical Products First Quarter 2012 Sales Rose 16% to a Record $30.8 Million; Highest Sales Quarter in Company History 5/3/12 Business Wire

Winners Announced at Second-Annual THE Aesthetic Awards(TM): "The Oscars of Aesthetic Medicine" 4/16/12 GlobeNewswire

Obagi Medical Products to Report First Quarter 2012 Financial Results and Host a Conference Call on May 3 4/11/12 Business Wire

THE Aesthetic Show(TM) Announces THE Best Aesthetic Products Awards 4/2/12 GlobeNewswire

Obagi Medical Products to Present at The 11th Annual Needham Healthcare Conference 3/23/12 Business Wire

Discovery Day to Kick Off B. Riley 13th Annual Investor Conference May 21-23, 2012 in Santa Monica 3/21/12 Business Wire

Obagi® Medical Products Presents Study Results at American Academy of Dermatology 3/20/12 Business Wire

Leaders in Global Aesthetic Medicine Headline Program at THE Aesthetic Show(TM) 2012 3/15/12 GlobeNewswire

Aesthetic TV Comes to THE Aesthetic Show(TM) April 12-16 in Las Vegas 3/9/12 GlobeNewswire

Obagi Medical Products Reports Sales and Earnings Growth for the Fourth Quarter and Year Ended December 31, 2011 3/8/12 Business Wire

Get the latest OMPI stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Obagi Medical Products, Inc. stock price.

Obagi Medical Products, Inc. by YCharts

Obagi Medical Products (OMPI) 12.62 -0.12

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On OMPI

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social